Candida infection adverse event reports that record this term

Kind of term: MedDRA preferred term
Plain meaning: thrush, a yeast infection

What a report is

A report is not proof that the drug was the cause of the event.

FDA says:

Adverse event reports submitted to FDA do not undergo extensive validation or verification. Therefore, a causal relationship cannot be established between product and reactions listed in a report. While a suspected relationship may exist, it is not medically validated and should not be the sole source of information for clinical decision making or other assumptions about the safety or efficacy of a product. Additionally, it is important to remember that adverse event reports represent a small percentage of total usage numbers of a product. Common products may have a higher number of adverse events due to the higher total number of people using the product.
Source: openFDA, Drug Adverse Event Overview, section "Responsible use of the data". The site read the page on 2 Oct 2026. The data have the reports that FDA received through 30 Jun 2026.

FDA also says:

There is no certainty that the reported event (adverse event or medication error) was actually due to the product. FDA does not require that a causal relationship between a product and event be proven, and reports do not always contain enough detail to properly evaluate an event. The information in these reports has not been scientifically or otherwise verified as to a cause and effect relationship and cannot be used to estimate the incidence of these events.
Source: openFDA, Drug Adverse Event Overview. The site read the page on 2 Oct 2026.

Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated.
Source: openFDA, Response of the drug event API (meta.disclaimer). The site read the page on 2 Oct 2026.

Not medical advice. This site counts what was reported to FDA. Questions about a medicine or device belong with a pharmacist or clinician.

Reports on file

From May 2005 to June 2026, FDA received 16,463 adverse event reports that record the MedDRA preferred term Candida infection. In plain words, the term means: thrush, a yeast infection. The person who codes a report selects the term that agrees best with the description of the reporter.

FDA received 1,403 reports in the 12 months to June 2026 and 1,248 in the 12 months before. FDA releases FAERS data every quarter, so the newest months are not complete. They grow in later releases.

By reports in the 12 months to June 2026, this term was number 481 of 1,436 reaction terms with a page. Of the 1,332,454 drug reports that FDA received in the 12 months to June 2026, 1,403 (0.1%) record this term. Reports for patients aged 45 to 64 were 25.5% of the reports that record this term and 20% of all drug reports.

The number of people who use the product is not in the data. A count is not a rate.

MedDRA

The Medical Dictionary for Regulatory Activities. The person who codes a report selects the preferred term that agrees best with the description of the reporter. FDA does not publish the description.

Plain meaning

Thrush, a yeast infection. The words are from the fixed dictionary of this site. They add nothing to a report.

Data version

openFDA FAERS release of 29 Oct 2026. Reports received through 30 Jun 2026.

Drugs in these reports

The table has the 149 drug pages with 50 or more reports that record this term. The rows are in order of name. A drug page with fewer reports for this term is not in the table. The counts are the counts that the site keeps for each reaction term, and a count can be lower than the count of FDA.

FDA says:

Additionally, it is important to remember that adverse event reports represent a small percentage of total usage numbers of a product. Common products may have a higher number of adverse events due to the higher total number of people using the product.
Source: openFDA, Drug Adverse Event Overview. The site read the page on 2 Oct 2026.

Importantly, the AEMS data by themselves are not an indicator of the safety profile of the drug or biologic.
Source: FDA, FDA Adverse Event Monitoring System (AEMS) Public Dashboard. Content current as of 11 Mar 2026. The site read the page on 2 Oct 2026.

Drugs that the reports with the term Candida infection name as a suspect product, in order of name
Drug	Class	Reports with this term
Acetaminophen		52
Actemra	Interleukin-6 receptor antagonist	143
Adalimumab	Tumor necrosis factor blocker	81
Advair Diskus	Corticosteroid	285
Advair Hfa	Corticosteroid	183
Afinitor	Kinase inhibitor	50
Albuterol	beta2-Adrenergic agonist	74
Albuterol sulfate	beta2-Adrenergic agonist	104
Alemtuzumab	CD52-directed cytolytic antibody	78
Amikacin	Aminoglycoside antibacterial	98
Amoxicillin	Penicillin-class antibacterial	126
Amphotericin b	Lipid-based polyene antifungal	133
Ampicillin	Penicillin-class antibacterial	68
Anidulafungin	Echinocandin antifungal	68
Anoro Ellipta	Anticholinergic	85
Arava	Antirheumatic agent	169
Aspirin	Nonsteroidal anti-inflammatory drug	65
Azathioprine	Purine antimetabolite	187
Basiliximab	Interleukin-2 receptor blocking antibody	97
Bendamustine		55
Bevacizumab	Vascular endothelial growth factor inhibitor	60
Bimekizumab		109
Bimzelx		350
Bleomycin	Cytoprotective agent	68
Bortezomib	Proteasome inhibitor	109
Breo Ellipta	Corticosteroid	346
Breztri	Corticosteroid	111
Budesonide	Corticosteroid	81
Busulfan	Alkylating drug	98
Cabometyx	Kinase inhibitor	91
Capecitabine	Nucleoside metabolic inhibitor	104
Carboplatin	Platinum-based drug	146
Caspofungin		83
Cefepime	Cephalosporin antibacterial	53
Ceftriaxone	Cephalosporin antibacterial	97
Celebrex	Nonsteroidal anti-inflammatory drug	114
Certolizumab pegol	Tumor necrosis factor blocker	51
Ciclosporin		95
Cimzia	Tumor necrosis factor blocker	81
Ciprofloxacin	Fluoroquinolone antibacterial	214
Cisplatin	Platinum-based drug	163
Clarithromycin	Macrolide antimicrobial	81
Clindamycin	Lincosamide antibacterial	53
Colace		50
Cosentyx	Interleukin-17A antagonist	563
Cyclophosphamide	Alkylating drug	632
Cyclosporine	Calcineurin inhibitor immunosuppressant	219
Cytarabine	Nucleoside metabolic inhibitor	304
Dacarbazine	Alkylating drug	59
Dapagliflozin	Sodium-Glucose cotransporter 2 inhibitor	118
Daptomycin		90
Daunorubicin		109
Denosumab	RANK ligand inhibitor	64
Dexamethasone	Corticosteroid	522
Diclofenac	Nonsteroidal anti-inflammatory drug	56
Docetaxel	Microtubule inhibitor	95
Doxorubicin	Anthracycline topoisomerase inhibitor	290
Doxorubicin hydrochloride	Anthracycline topoisomerase inhibitor	121
Dulera	Corticosteroid	74
Dupixent	Interleukin-4 receptor alpha antagonist	198
Empagliflozin	Sodium-Glucose cotransporter 2 inhibitor	61
Enbrel	Tumor necrosis factor blocker	361
Estradiol	Estrogen	57
Etoposide	Topoisomerase inhibitor	364
Faslodex	Estrogen receptor antagonist	52
Filgrastim	Leukocyte growth factor	58
Fluconazole	Azole antifungal	404
Fludarabine	Nucleoside metabolic inhibitor	134
Fludarabine phosphate	Nucleoside metabolic inhibitor	57
Fluorouracil	Nucleoside metabolic inhibitor	81
Fluticasone propionate and salmeterol	Corticosteroid	56
Gentamicin	Aminoglycoside antibacterial	76
Human immunoglobulin g	Human immunoglobulin G	137
Humira		540
Hydrocortisone	Corticosteroid	150
Hydroxychloroquine	Antimalarial	123
Hydroxychloroquine sulfate	Antimalarial	54
Ibrance	Kinase inhibitor	92
Ibuprofen	Nonsteroidal anti-inflammatory drug	50
Ifosfamide	Alkylating drug	84
Imbruvica	Kinase inhibitor	70
Infliximab	Tumor necrosis factor blocker	87
Jardiance	Sodium-Glucose cotransporter 2 inhibitor	107
Kadcyla		67
Leflunomide	Antirheumatic agent	125
Lenalidomide	Thalidomide analog	70
Levofloxacin	Fluoroquinolone antibacterial	117
Linezolid	Oxazolidinone antibacterial	120
Melphalan	Alkylating drug	104
Meropenem	Penem antibacterial	265
Methotrexate	Folate analog metabolic inhibitor	725
Methotrexate sodium	Folate analog metabolic inhibitor	137
Methylprednisolone	Corticosteroid	551
Methylprednisolone sodium succinate	Corticosteroid	74
Metronidazole	Nitroimidazole antimicrobial	130
Micafungin	Echinocandin antifungal	104
Mycophenolate mofetil	Antimetabolite immunosuppressant	532
Mycophenolic acid	Antimetabolite immunosuppressant	106
Neulasta	Leukocyte growth factor	51
Nystatin		151
Ocrevus	CD20-directed cytolytic antibody	140
Omeprazole	Proton pump inhibitor	77
Orencia	Selective T cell costimulation modulator	206
Oxaliplatin	Platinum-based drug	78
Oxycodone hydrochloride	Opioid agonist	61
Paclitaxel	Microtubule inhibitor	57
Pantoprazole	Proton pump inhibitor	88
Pegasys	Interferon alpha	63
Pertuzumab	HER2/neu receptor antagonist	57
Piperacillin and tazobactam	Penicillin-class antibacterial	93
Piperacillin sodium,tazobactam sodium		67
Plaquenil	Antimalarial	56
Pomalyst	Thalidomide analog	64
Posaconazole	Azole antifungal	51
Prednisolone	Corticosteroid	524
Prednisone	Corticosteroid	1,045
Remicade	Tumor necrosis factor blocker	141
Revlimid	Thalidomide analog	213
Ribavirin	Nucleoside analog antiviral	75
Rinvoq	Janus kinase inhibitor	81
Rituxan	CD20-directed cytolytic antibody	118
Rituximab	CD20-directed cytolytic antibody	626
Simponi	Tumor necrosis factor blocker	72
Skyrizi	Interleukin-23 antagonist	53
Soliris	Complement inhibitor	60
Stelara	Interleukin-12 antagonist	84
Sulfasalazine	Aminosalicylate	169
Symbicort	Corticosteroid	386
Tacrolimus	Calcineurin inhibitor immunosuppressant	698
Taltz	Interleukin-17A antagonist	135
Tecfidera		75
Thiotepa	Alkylating drug	51
Thymoglobulin	Immunoglobulin G	70
Tiotropium bromide	Anticholinergic	165
Tocilizumab	Interleukin-6 receptor antagonist	139
Trastuzumab	HER2/neu receptor antagonist	90
Trelegy Ellipta	Anticholinergic	411
Tykerb	Kinase inhibitor	50
Tysabri	Integrin receptor antagonist	60
Tyvaso	Prostacycline vasodilator	76
Vancomycin	Glycopeptide antibacterial	256
Venetoclax	BCL-2 inhibitor	52
Vincristine		343
Vincristine sulfate	Vinca alkaloid	116
Voriconazole	Azole antifungal	150
Xeljanz	Janus kinase inhibitor	192
Xeloda	Nucleoside metabolic inhibitor	82
Xolair	Anti-IgE	67
Zometa		60

The page of each drug has the count of each reaction term in its reaction lookup.

Drug classes in these reports

The table has the 57 pharmacologic classes with 100 or more reports that record this term. The rows are in order of name.

FDA says:

Additionally, it is important to remember that adverse event reports represent a small percentage of total usage numbers of a product. Common products may have a higher number of adverse events due to the higher total number of people using the product.
Source: openFDA, Drug Adverse Event Overview. The site read the page on 2 Oct 2026.

Importantly, the AEMS data by themselves are not an indicator of the safety profile of the drug or biologic.
Source: FDA, FDA Adverse Event Monitoring System (AEMS) Public Dashboard. Content current as of 11 Mar 2026. The site read the page on 2 Oct 2026.

Pharmacologic classes of the drugs that the reports with the term Candida infection name, in order of name
Class	Reports with this term
Alkylating drug	1,122
Aminoglycoside antibacterial	258
Aminosalicylate	181
Anthracycline topoisomerase inhibitor	461
Anticholinergic	804
Antimalarial	242
Antimetabolite immunosuppressant	681
Antirheumatic agent	294
Azole antifungal	721
beta2-Adrenergic agonist	271
Bisphosphonate	103
Calcineurin inhibitor immunosuppressant	1,017
CD20-directed cytolytic antibody	945
CD52-directed cytolytic antibody	103
Cephalosporin antibacterial	287
Corticosteroid	4,834
Cytoprotective agent	112
Dihydrofolate reductase inhibitor antibacterial	126
Echinocandin antifungal	225
Endothelin receptor antagonist	126
Factor Xa inhibitor	119
Fluoroquinolone antibacterial	350
Folate analog metabolic inhibitor	890
Glycopeptide antibacterial	281
HER2/neu receptor antagonist	235
Human immunoglobulin G	228
Interleukin-17A antagonist	720
Interleukin-2 receptor blocking antibody	106
Interleukin-4 receptor alpha antagonist	216
Interleukin-6 receptor antagonist	295
Janus kinase inhibitor	386
Kinase inhibitor	909
Leukocyte growth factor	136
Lipid-based polyene antifungal	149
Macrolide antimicrobial	122
Microtubule inhibitor	167
Nitroimidazole antimicrobial	145
Nonsteroidal anti-inflammatory drug	328
Nucleoside metabolic inhibitor	910
Opioid agonist	239
Oxazolidinone antibacterial	130
Penem antibacterial	271
Penicillin-class antibacterial	341
Platinum-based drug	387
Programmed death Receptor-1 blocking antibody	184
Prostacycline vasodilator	183
Proteasome inhibitor	170
Proton pump inhibitor	304
Purine antimetabolite	210
RANK ligand inhibitor	139
Selective T cell costimulation modulator	252
Sodium-Glucose cotransporter 2 inhibitor	351
Thalidomide analog	355
Topoisomerase inhibitor	424
Tumor necrosis factor blocker	973
Vascular endothelial growth factor inhibitor	113
Vinca alkaloid	141

A class with many reports in all has many reports for almost every term.

Reports by month

Reports that record Candida infection, by month, five years to June 2026

FDA releases FAERS data every quarter, so the newest months are not complete. They grow in later releases.

Patients in these reports

Age of the patient in the reports that record Candida infection
Age	Reports	Share
Under 2	156	0.9%
2 to 11	320	1.9%
12 to 17	219	1.3%
18 to 44	2,177	13.2%
45 to 64	4,196	25.5%
65 to 74	2,364	14.4%
75 and over	1,391	8.4%
Age not given	5,640	34.3%

Sex of the patient in the reports that record Candida infection
Sex	Reports	Share
Female	9,369	56.9%
Male	5,029	30.5%
Unknown or not given	2,065	12.5%

Age and sex are as the report gives them. 59.5% of these reports give the United States as the country.

Terms near this one

These are the next terms in the A to Z list. The links are for navigation.

Official pages

MedWatch Online Voluntary Reporting FormThe online form of FDA for a voluntary report.
MedWatch: The FDA Safety Information and Adverse Event Reporting ProgramThe page of the FDA program that receives reports about drugs and devices.
FDA Adverse Event Monitoring System (AEMS) Public DashboardThe public dashboard of FDA for adverse event reports on drugs and biologics.

The site checked these addresses on 2 Oct 2026. The links open in a new tab.

Cite this page

Reported Reactions. Candida infection: adverse event reports that record this term. https://reportedreactions.com/reaction/candida-infection/ Source: U.S. Food and Drug Administration, openFDA Drug Adverse Event (FAERS) files, release of 29 Oct 2026. Reports received through 30 Jun 2026.

Where the data come from

The counts come from the openFDA Drug Adverse Event (FAERS) bulk files, release of 29 Oct 2026. The files have the reports that FDA received through 30 Jun 2026. A drug name is the name on the report. The site matches it to a brand name or a generic name of the National Drug Code Directory of 2 Nov 2026. A class is the pharmacologic class (EPC) of the FDA label.

The count has the reports with each spelling of one MedDRA preferred term. The site does not publish a report narrative, a lot number, a detail of a patient or the identity of a reporter. The record of FDA is the authority. See how the site counts reports, the data sources and the corrections page.

Questions

What does Candida infection mean in an adverse event report?

In plain words: thrush, a yeast infection. It is a MedDRA preferred term. FDA codes the description of a reporter with the MedDRA dictionary. The openFDA files do not have the description itself, and this site does not show it.

Does a drug in the table mean that the drug was responsible for this reaction?

No. FDA says:

No individual drug is connected to any individual reaction.
Source: openFDA, Drug Adverse Event Overview. The site read the page on 2 Oct 2026.

When a report lists multiple drugs and multiple reactions, there is no way to conclude from the data therein that a given drug is responsible for a given reaction.
Source: openFDA, Drug Adverse Event Overview. The site read the page on 2 Oct 2026.

What does this page tell a person who has this symptom?

This page gives counts of reports. It cannot assess a person. A pharmacist or a clinician can assess a person.

If this is a medical emergency, please call 911.
Source: FDA, MedWatch Online Voluntary Reporting Form. The site read the page on 2 Oct 2026.

To the top of the page